公司概覽
業務類別 --
業務概覽 Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
公司地址 85 Wells Avenue, 2nd Floor, Newton, MA, USA, 02459
電話號碼 +1 617 658-0600
傳真號碼 --
公司網頁 https://www.karyopharm.com
員工數量 228
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Michael Mason, C.P.A.,M.B.A. Executive Vice President, Chief Financial Officer, Treasurer and Principal Accounting Officer 美元 500.32K 29/08/2024
Dr. Sharon Shacham, M.B.A.,PhD Chief Scientific Officer 美元 499.91K 01/03/2022
Mr. Ran Frenkel, R.Ph. Executive Vice President and Chief Development Officer 美元 429.53K 01/03/2022
Dr. Stephen Mitchener, Pharm.D. Senior Vice President and Chief Business Officer -- 17/02/2023
Mr. Richard Paulson, M.B.A. Director, President and Chief Executive Officer 美元 770.00K 13/04/2026
Dr. Reshma Rangwala, M.D.,PhD Executive Vice President and Chief Medical Officer 美元 567.74K 13/02/2026
Mr. Michael Mano, J.D. Executive Vice President, Chief Legal Officer and Secretary -- 13/02/2026
Ms. Lori Macomber, C.P.A. Executive Vice President, Chief Financial Officer and Treasurer -- 13/02/2026
Ms. Sohanya Roshan Cheng, M.B.A. Executive Vice President and Chief Commercial Officer -- 13/02/2026
Mr. Stuart Poulton Executive Vice President and Chief Development Officer 美元 500.14K 13/02/2026
Ms. Kristin Abate Vice President, Chief Accounting Officer, and Assistant Treasurer -- 13/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Barry E. Greene Lead Independent Director 13/04/2026
Mr. Chen Schor, M.B.A. Independent Director 13/04/2026
Mr. Garen G. Bohlin Independent Director 13/04/2026
Dr. Deepika Rachel Pakianathan Independent Director 13/04/2026
Dr. Peter K. Honig, M.D.,M.P.H. Independent Director 08/12/2023
Dr. Mansoor Raza Mirza, M.D. Independent Director 14/04/2025
Mr. Richard Paulson, M.B.A. Director, President and Chief Executive Officer 13/04/2026
Ms. Christy J. Oliger Independent Director 13/04/2026
Dr. Zhen Su Independent Director 13/04/2026
 
所屬ETF (更新日期: 12/11/2026 02:25)
代號 名稱 佔比% ▼ 持有日期
FHLCFidelity® MSCI Health Care ETF<0.000001%06/09/2023
FSEGFidelity Enhanced Small Cap Growth ETF<0.000001%09/09/2026
FSEVFidelity Enhanced Small Cap Value ETF<0.000001%09/09/2026
FTLSFirst Trust Long/Short Equity ETF<0.000001%03/06/2021
FYCFirst Trust Small Cap Gr AlphaDEX® ETF<0.000001%08/01/2021
FYXFirst Trust Small Cap Core AlphaDEX® ETF<0.000001%08/01/2021
GSSCGoldman Sachs ActiveBeta® US SmCp Eq ETF<0.000001%21/09/2026
GUGGuggenheim Active Allocation Fund<0.000001%31/08/2022
HKNDHumankind US Stock ETF<0.000001%23/05/2022
HQHTekla Healthcare Investors<0.000001%31/03/2021
IBBiShares Biotechnology ETF<0.000001%19/12/2023
IBBQInvesco Nasdaq Biotechnology ETF<0.000001%18/12/2023
IDNAiShares Genomics Immnlgy & Hlthcr ETF<0.000001%19/12/2023
ISCGiShares Morningstar Small-Cap Growth ETF<0.000001%19/12/2023
ISCViShares Morningstar Small-Cap Value ETF<0.000001%19/12/2023
ITOTiShares Core S&P Total US Stock Mkt ETF<0.000001%06/03/2026
IWViShares Russell 3000 ETF<0.000001%06/03/2026
LABUDirexion Daily S&P Biotech Bull 3X ETF<0.000001%20/06/2023
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF<0.000001%31/07/2024
ONEQFidelity® Nasdaq Composite ETF<0.000001%31/12/2020
  1    2   3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.